Medication adjustments for women after heart failure hospitalization
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether adjusting heart failure medications in women can improve their recovery and outcomes. It focuses on women who have been recently hospitalized for acute heart failure and are not yet on optimal medication doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman between 18 and 85 years old.
- You must have been hospitalized for acute heart failure within the last 3 days, with symptoms like shortness of breath and fluid buildup.
- Your blood pressure and heart rate must be stable (above certain levels) within 24 hours before starting the study.
- Your potassium levels must be within a safe range.
- You must have elevated NT-proBNP blood test results twice, showing your heart failure is not fully resolved.
- You must be on less than half the recommended dose of certain heart failure medications, or not taking an SGLT2 inhibitor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
This study tests whether remote check-ins via phone or video can help safely increase heart failure medications to target doses. You'll use a device to share weight, blood pressure, and heart rate with your doctor, who will adjust your medicines based on how you're doing.
This study is testing different ways to safely increase the doses of standard heart failure medicines while you are still in the hospital. The goal is to find the best strategy to help your heart work better before you go home.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
This study tests a personalized approach to safely increase the dose of your heart failure medication (beta-blocker). It aims to improve your symptoms and overall heart function by tailoring the dose to your specific needs.
This trial tests a program to manage heart failure at home after you leave the hospital. It aims to safely adjust your medications to optimal doses while you recover at home.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.